Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead
Go back to Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead| AGENUS (NASDAQ: AGEN) | Delayed: 7.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.49 | 52 Week High | $7.49 | |||
| Open | $7.49 | 52 Week Low | $2.61 | |||
| Day High | $7.49 | P/E | N/A | |||
| Day Low | $7.49 | EPS | $-1.10 | |||
| Volume | 6,370 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $143.44 | 52 Week Low | $71.39 | |||
| Day High | $143.44 | P/E | 79.25 | |||
| Day Low | $143.44 | EPS | $1.81 | |||
| Volume | 1,969 | |||||

